Suppr超能文献

一种针对p53癌症突变体的全局抑制基序。

A global suppressor motif for p53 cancer mutants.

作者信息

Baroni Timothy E, Wang Ting, Qian Hua, Dearth Lawrence R, Truong Lan N, Zeng Jue, Denes Alec E, Chen Stephanie W, Brachmann Rainer K

机构信息

Department of Medicine, Division of Oncology, Washington University School of Medicine, 660 South Euclid Avenue, P.O. Box 8069, St. Louis, MO 63110, USA.

出版信息

Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4930-5. doi: 10.1073/pnas.0401162101. Epub 2004 Mar 22.

Abstract

The transcription factor and tumor suppressor protein p53 is frequently inactivated in human cancers. In many cases, p53 gene mutations result in high levels of inactive, full-length p53 protein with one amino acid change in the core domain that recognizes p53 DNA-binding sites. The ability to endow function to mutated p53 proteins would dramatically improve cancer therapy, because it would reactivate a central apoptotic pathway. By using genetic strategies and p53 assays in yeast and mammalian cells, we identified a global suppressor motif involving codons 235, 239, and 240. These intragenic suppressor mutations, either alone or in combination, restored function to 16 of 30 of the most common p53 cancer mutants tested. The 235-239-240 suppressor motif establishes that manipulation of a small region of the core domain is sufficient to activate a large number of p53 cancer mutants. Understanding the structural basis of the rescue mechanism will allow the pursuit of small compounds able to achieve a similar stabilization of p53 cancer mutants.

摘要

转录因子及肿瘤抑制蛋白p53在人类癌症中常常失活。在许多情况下,p53基因突变会导致高水平的无活性全长p53蛋白,其核心结构域中有一个氨基酸发生改变,该结构域负责识别p53的DNA结合位点。赋予突变型p53蛋白功能的能力将极大地改善癌症治疗,因为这将重新激活一条核心凋亡途径。通过在酵母和哺乳动物细胞中运用遗传学策略及p53检测方法,我们确定了一个涉及密码子235、239和240的全局抑制基序。这些基因内抑制突变单独或组合使用时,可使所检测的30种最常见p53癌症突变体中的16种恢复功能。235 - 239 - 240抑制基序表明,对核心结构域的一个小区域进行操控就足以激活大量p53癌症突变体。了解挽救机制的结构基础将有助于研发能够使p53癌症突变体实现类似稳定化的小分子化合物。

相似文献

1
A global suppressor motif for p53 cancer mutants.一种针对p53癌症突变体的全局抑制基序。
Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4930-5. doi: 10.1073/pnas.0401162101. Epub 2004 Mar 22.

引用本文的文献

4
Small-molecule correctors and stabilizers to target p53.靶向 p53 的小分子矫正剂和稳定剂。
Trends Pharmacol Sci. 2023 May;44(5):274-289. doi: 10.1016/j.tips.2023.02.007. Epub 2023 Mar 22.
5
Mechanistic insights into global suppressors of protein folding defects.蛋白质折叠缺陷的全局抑制剂的机制见解。
PLoS Genet. 2022 Aug 29;18(8):e1010334. doi: 10.1371/journal.pgen.1010334. eCollection 2022 Aug.
10
Structural and Drug Targeting Insights on Mutant p53.突变型p53的结构与药物靶向见解
Cancers (Basel). 2021 Jul 3;13(13):3344. doi: 10.3390/cancers13133344.

本文引用的文献

6
Therapeutic exploitation of the p53 pathway.p53 通路的治疗性应用。
Trends Mol Med. 2002;8(4 Suppl):S38-42. doi: 10.1016/s1471-4914(02)02309-2.
7
Rescuing the function of mutant p53.恢复突变型p53的功能。
Nat Rev Cancer. 2001 Oct;1(1):68-76. doi: 10.1038/35094077.
9
hADA3 is required for p53 activity.p53活性需要hADA3。
EMBO J. 2001 Nov 15;20(22):6404-13. doi: 10.1093/emboj/20.22.6404.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验